RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Oseltamivir 복용 이후 소아에서 발생한 이상행동 및 그 인과성 평가 = Psychiatric Symptoms after Taking Oseltamivir in a Child and Its Causality Assessment

      한글로보기

      https://www.riss.kr/link?id=A106106112

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Oseltamivir is an antiviral medication prescribed to prevent and treat influenza A and B. A case from a community pharmacy in Korea was reported for an adverse event associated with oseltamivir administration. A 20-month-old boy had psychiatric sympto...

      Oseltamivir is an antiviral medication prescribed to prevent and treat influenza A and B. A case from a community pharmacy in Korea was reported for an adverse event associated with oseltamivir administration. A 20-month-old boy had psychiatric symptoms after receiving 2 doses of oseltamivir. Therefore, an evaluation of whether the psychiatric symptoms were caused by oseltamivir was required. To determine whether the adverse event resulted from the administrated medication or other factors, three tools were used: the Naranjo scale, the Korean causality assessment algorithm (Ver.2), and the World Health Organization-Uppsala Monitoring Center (WHO-UMC) criteria. The psychiatric symptoms occurred after oseltamivir administration, and were attenuated after oseltamivir termination. A possible cause of the psychiatric symptoms is high fever, but information on the body temperature of the patient was not sufficient. Therefore, it was unclear whether there were other nonpharmacological causes of adverse drug reaction.
      For these reasons, in terms of causality, the results evaluated by the three tools represented, "possible", "probable", and "probable/ likely", respectively.

      더보기

      참고문헌 (Reference)

      1 Dailypharm, "‘The evolutionary generic medications as game changers’ pushing out the original medications"

      2 Ono H, "Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)" 138 (138): 1201-1215, 2018

      3 Sogabe K, "Safety and efficacy of midazolam in children under mechanical ventilation in the intensive care unit" 61 (61): 1245-1260, 2012

      4 전상원, "Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report" 대한정신약물학회 13 (13): 209-211, 2015

      5 Tsz-Yin So, "Oseltamivir and Neuropsychiatric Behaviors - A Case Report on an Adolescent Teen and Evaluation of the Literature" 1 (1): 1-6, 2009

      6 "Mayo Clinic School of Continuous Professional Development"

      7 이희영, "Levosulpiride 복용 이후 발생한 고프로락틴혈증 및 그 인과성 분석: 지역약국에서 보고된 부작용 증례" 한국임상약학회 28 (28): 154-157, 2018

      8 Korean Index of Medical Specialties, "Ingredient information"

      9 Centers for Disease Control and Prevention, "Influenza (Flu)"

      10 Korea Centers for Disease Control and Prevention, "Infectious Disease Portal"

      1 Dailypharm, "‘The evolutionary generic medications as game changers’ pushing out the original medications"

      2 Ono H, "Similarity of Clinically Significant Neuropsychiatric Adverse Reactions Listed in Package Inserts between the Anti-influenza Drugs Oseltamivir and Amantadine (Possibility Attributable to Common Pharmacological Effects)" 138 (138): 1201-1215, 2018

      3 Sogabe K, "Safety and efficacy of midazolam in children under mechanical ventilation in the intensive care unit" 61 (61): 1245-1260, 2012

      4 전상원, "Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report" 대한정신약물학회 13 (13): 209-211, 2015

      5 Tsz-Yin So, "Oseltamivir and Neuropsychiatric Behaviors - A Case Report on an Adolescent Teen and Evaluation of the Literature" 1 (1): 1-6, 2009

      6 "Mayo Clinic School of Continuous Professional Development"

      7 이희영, "Levosulpiride 복용 이후 발생한 고프로락틴혈증 및 그 인과성 분석: 지역약국에서 보고된 부작용 증례" 한국임상약학회 28 (28): 154-157, 2018

      8 Korean Index of Medical Specialties, "Ingredient information"

      9 Centers for Disease Control and Prevention, "Influenza (Flu)"

      10 Korea Centers for Disease Control and Prevention, "Infectious Disease Portal"

      11 Chosun, "I got the flu even though I got vaccinated...WHO’s missed prediction"

      12 Hama R, "Fatal neuropsychiatric adverse reactions to osletamivir:Case series and overview of causal relationships" 20 (20): 5-36, 2008

      13 University of Virginia School of Medicine, "Department of Periatrics"

      14 Dailypharm, "An epidemic of influenza; transition to generic competition...“Hanmiflu smiled”"

      15 Dalvi PS, "Adverse drug reaction profile of oseltamivir in children" 2 (2): 100-103, 2011

      16 Health Sciences Authority, "Adverse Drug Reaction news"

      17 Leentjens AF, "A comparison of the phenomenology of pediatric, adult, and geriatric delirium" 64 (64): 219-223, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-05-10 학술지등록 한글명 : 한국임상약학회지
      외국어명 : Korean Journal of Clinical Pharmacy
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.17
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.15 0.432 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼